The U.S. Food and Drug Administration recognized depression as a potential side effect of finasteride in 2011 and recognized suicidality as a potential side effect in 2022.
January 01, 2011
high
temporal
Regulatory labeling acknowledgments by the FDA regarding neuropsychiatric adverse effects of finasteride.
The U.S. Food and Drug Administration recorded 18 suicides linked to finasteride in 2011.
January 01, 2011
high
statistical
A reported count of suicide cases associated with finasteride in FDA records for 2011.
Studies as early as 2002 raised concerns linking finasteride with an increased risk of depression and suicide.
January 01, 2002
high
temporal
Early scientific and clinical reports identifying potential neuropsychiatric risks associated with finasteride.
Finasteride is a medication prescribed to treat androgenetic alopecia, which is the most common form of baldness.
high
definitional
Describes the clinical indication of the drug finasteride.